A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy

Clinical trial NCT07210723 · RECRUITING

Trial details

NCT number: NCT07210723
Sponsor: Kardigan, Inc.
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Symptomatic Genetic Dilated Cardiomyopathy

Start date: 2026-02-13
Primary completion: 2027-09-01
Enrollment: 332

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.